A PQQ-probiotic composite microcapsule, its preparation method and application
By loading PQQ and probiotics onto a mesoporous silica carrier with a spatial partitioned structure and combining it with an enteric polymer cross-linking layer, the problems of osmotic pressure damage and activity limitation of PQQ and probiotics were solved, achieving intestinal targeted delivery and time-sequential synergistic release, and improving the gastric acid tolerance and storage stability of probiotics.
Patent Information
- Application Number
- CN202611601289.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-10-16
- Publication Date
- 2026-11-17
AI Technical Summary
In existing technologies, the simple physical mixing of PQQ with probiotics leads to osmotic pressure inhibition of probiotic activity, and silica encapsulation restricts probiotic activity, making it impossible to achieve intestinal targeted delivery and time-sequential synergistic release.
PQQ is loaded onto a mesoporous silica carrier, and probiotics are adsorbed onto the outer surface to construct an antioxidant microenvironment. The enteric polymer cross-linking layer enables sequential cascade release in the intestine.
It improves the gastric acid tolerance and room temperature storage stability of probiotics, and achieves efficient synergistic delivery of PQQ and probiotics and intestinal repair effects.
Smart Images

Figure CN123100832A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of advanced inorganic non-metallic materials and functional composite materials, and particularly relates to a PQQ and probiotic composite microcapsule, its preparation method and application. Background Technology
[0002] Pyrroloquinoline quinone (PQQ) is a novel coenzyme-like bioactive substance, hailed as a "super antioxidant," showing great potential in anti-aging, neuroprotection, cardiovascular health, and mitochondrial function activation. However, PQQ is chemically unstable, sensitive to light and heat, and easily degrades in the acidic environment of the stomach (pH 1.5–2.0), resulting in low oral bioavailability. Achieving effective encapsulation and intestinal-targeted delivery of PQQ is one of the key technical challenges that urgently needs to be addressed in this field.
[0003] Probiotics are core functional components in regulating the gut microbiota, improving host gut health through mechanisms such as competitive colonization, production of antimicrobial substances, and regulation of immune responses. However, probiotics are highly susceptible to inactivation due to environmental stresses such as oxygen free radicals, temperature, and humidity during processing, storage, and oral administration; their survival rate is particularly low when exposed to the acidic environment of the stomach. Therefore, improving the stomach acid tolerance and room temperature storage stability of probiotics has always been a research hotspot in the field of probiotic formulations.
[0004] Theoretically, combining PQQ with probiotics offers a synergistic advantage of "regulating the gut and activating cellular energy." However, current technologies typically involve a simple physical dry mixing of PQQ and probiotics. This method has several drawbacks: First, due to the lack of spatial isolation, the dissolution of high-concentration PQQ can create osmotic pressure, potentially inhibiting probiotic activity. Second, simple physical mixing cannot address the extreme sensitivity of both PQQ and probiotics to stomach acid. Third, when PQQ comes into direct contact with probiotics, the strong redox activity of PQQ may adversely affect the probiotic cell membrane.
[0005] On the other hand, some existing research attempts to improve bacterial stability by directly encapsulating probiotics in silica. For example, a silica shell is formed on the surface of probiotic cells using the sol-gel method, or mesoporous silica nanoparticles are used to encapsulate probiotics. However, this method of completely encapsulating probiotics inside a rigid silica shell has significant drawbacks: the dense, rigid inorganic silica shell severely hinders the exchange of nutrients between probiotics and the external environment, leading to a decrease in bacterial metabolic activity; and after entering the intestines, the hard silica shell is difficult to degrade quickly, resulting in slow release and difficulty in proliferation of probiotics, greatly limiting their biological activity.
[0006] Furthermore, while there are reports of loading PQQ into mesoporous silica channels in existing technologies, these are mostly used in detection applications or for the delivery of single active ingredients, and do not involve the co-loading and spatial partitioning design of probiotics. Meanwhile, current probiotic microcapsule technologies mostly use polysaccharide materials such as sodium alginate and chitosan for single-layer or multi-layer encapsulation. Although this can provide a certain gastric acid barrier, it cannot create an antioxidant microenvironment within the microcapsule, nor can it achieve the time-sequential synergistic release of PQQ and probiotics.
[0007] Therefore, there is an urgent need to develop a novel spatial delivery carrier that can simultaneously protect PQQ and probiotics without restricting the physiological activity of probiotics, so as to achieve spatial isolation, antioxidant protection and sequential cascade release in the intestine. Summary of the Invention
[0008] To address the technical problems in existing technologies, such as the easy inactivation of probiotics when physically mixed with PQQ, poor tolerance to gastric acid, and the limitation of bacterial physiological activity by direct encapsulation of probiotics in silica, the present invention aims to provide a PQQ-probiotic composite microcapsule, its preparation method, and its application. This invention cleverly utilizes the pore size selectivity of mesoporous silica to achieve a "spatial partitioning" structure where PQQ is loaded within the pores and probiotics are adsorbed on the outer surface of the pores, completely avoiding osmotic pressure damage caused by direct contact between PQQ and probiotics. Simultaneously, the slow release of PQQ from the mesoporous pores constructs an antioxidant microenvironment within the microcapsule, significantly improving the survival rate of probiotics under gastric acid and room temperature storage conditions. Furthermore, the outermost enteric polymer cross-linking coating layer enables a time-cascaded release within the intestine, thereby simultaneously achieving efficient protection and synergistic delivery of both PQQ and probiotics.
[0009] To achieve the above objectives, the present invention adopts the following technical solution: This invention first provides a PQQ and probiotic composite microcapsule, which has a core-shell structure and includes, from the inside out, a core layer, a live bacteria layer, and a coating layer; the core layer is a mesoporous silica carrier loaded with PQQ or its disodium salt; the live bacteria layer is a probiotic group physically adsorbed and fixed on the outer surface of the core layer; and the coating layer is an enteric polymer cross-linked network layer wrapped around the outermost layer.
[0010] Preferably, the mesoporous silica support has an average pore size of 10–40 nm and a specific surface area of 10–100 m² before loading. 2 / g.
[0011] Preferably, the mass ratio of the core layer, the live bacteria layer (by dry weight), and the coating layer is (1-5):(0.1-1):(2-10).
[0012] Preferably, the probiotics are selected from one or more of Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, or Bacillus subtilis.
[0013] Preferably, the coating layer is made of sodium alginate or pectin, and is formed by cross-linking divalent metal calcium ions or zinc ions to form an enteric polymer cross-linked network layer.
[0014] Another object of the present invention is to provide a specific method for preparing the above-mentioned composite microcapsules, comprising the following steps: S0. Preparation of mesoporous silica support: Mesoporous silica support was prepared by a sol-gel combined with hydrothermal method with added pore-expanding agent; surfactant was weighed and dissolved in hydrochloric acid solution, pore-expanding agent was added and stirred homogeneously, and then tetraethyl orthosilicate was added dropwise to induce hydrolysis and polycondensation reaction; after the reaction was completed, it was transferred to a high-pressure reactor for high-temperature hydrothermal aging to expand the pores; after washing and drying, the product was placed in a muffle furnace for high-temperature calcination to remove the surfactant, thus obtaining a mesoporous silica support with large pore size and low specific surface area. S1. Pore loading: Prepare an aqueous solution of PQQ or its disodium salt with a concentration of 5-20 mg / mL, and disperse the mesoporous silica support obtained in step S0 in the aqueous solution; stir under constant temperature and in the dark for 12-24 hours to allow PQQ molecules to fully enter and be physically adsorbed and fixed inside the mesoporous channels; then centrifuge and wash with deionized water to remove unadsorbed free PQQ on the surface, and finally dry in a vacuum drying oven to obtain the core layer powder loaded with PQQ. S2, Live Bacteria Adsorption: Collect freshly cultured or resuspended probiotic suspensions; add the core layer powder obtained in step S1 to the bacterial suspension, and gently stir and adsorb for 1 to 3 hours in an environment of 4℃~25℃; in this step, larger probiotics cannot enter the mesoporous channels, but are physically adsorbed and fixed on the outer surface of the mesoporous silica carrier, thus obtaining a precursor complex with "PQQ inside and live bacteria outside". S3. Cross-linking and coating: The enteric polymer is dissolved in deionized water to prepare an enteric polymer aqueous solution; the above precursor complex is directly added to the enteric polymer aqueous solution and mixed evenly to form a coating solution; using a dropping device, the coating solution is dropped dropwise into a curing cross-linking solution containing divalent metal cations with a mass fraction controlled at 2% to 5%; the droplets undergo ion exchange and cross-linking reaction upon contact with the curing cross-linking solution, forming a dense microcapsule structure; after curing in the curing cross-linking solution for 30 to 60 minutes, it is filtered and collected, washed, and freeze-dried to finally obtain composite microcapsules in dry powder form.
[0015] Preferably, the surfactant in step S0 is a triblock copolymer P123, and the pore-expanding agent is 1,3,5-trimethylbenzene.
[0016] Preferably, the enteric polymer in step S3 is sodium alginate or pectin, and the divalent metal cation is calcium ion or zinc ion.
[0017] This invention also provides the application of the above-mentioned composite microcapsules in the preparation of foods, health products or drugs that improve intestinal microecology, promote intestinal mucosal repair or mitochondrial anti-aging.
[0018] The present invention further provides an end product that improves the gut microbiota, promotes intestinal mucosal repair, or has anti-aging effects on mitochondria. The end product comprises the above-mentioned composite microcapsules. The end product is a food, health product, special medical food, or drug.
[0019] Compared with the prior art, the beneficial effects of the present invention are reflected in: 1. This invention utilizes the pore size selectivity of mesoporous silica to allow PQQ molecules to enter and be loaded inside the mesoporous channels, while larger probiotics cannot enter the channels and are only adsorbed on the outer surface of the mesoporous silica. This achieves a spatial partitioning structure of "PQQ inside the pores and probiotics on the surface", which completely avoids osmotic pressure damage to probiotics caused by direct contact between the two and excessively high local concentration of PQQ.
[0020] 2. This invention utilizes trace amounts of PQQ slowly released within a mesoporous silica framework to continuously eliminate oxygen free radicals that have infiltrated from the external environment inside the microcapsule, thereby constructing a spontaneously formed antioxidant microenvironment inside. This greatly extends the shelf life of probiotics fixed on the surface at room temperature, effectively solving the industry pain point that probiotics are difficult to store at room temperature for a long time.
[0021] 3. This invention utilizes an outermost enteric polymer cross-linking coating layer, allowing the composite microcapsules to dissolve in the weakly alkaline intestinal fluid after entering the intestine. The outermost enteric coating is released first and colonizes the intestinal mucosa. Subsequently, PQQ in the internal mesoporous framework is released slowly, directly providing mitochondrial energy and coenzymes to the surrounding intestinal epithelial cells and the colonized probiotics, thereby achieving a spatiotemporal cascade synergistic repair effect of first regulating bacteria and then supplying energy.
[0022] 4. The composite microcapsules of the present invention significantly improve the gastric acid tolerance of probiotics. After being treated in a simulated gastric juice environment for the same period of time, the survival rate of live bacteria is much higher than that of pure probiotics and empty microcapsules without PQQ loading, thereby effectively ensuring the bioactivity of probiotics during oral delivery.
[0023] 5. This invention has a universal protective effect on a variety of common intestinal probiotics. Since probiotics such as Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, and Bacillus subtilis have homology and similarity in morphology, size and sensitivity mechanism to gastric acid and oxygen free radicals, the molecular sieving and microenvironment protection mechanism of this invention can be widely applied to the protection and delivery of various common intestinal probiotics. Attached Figure Description
[0024] Figure 1 A scanning electron microscope (SEM) image of the mesoporous silica carrier prepared for an embodiment of the present invention; Figure 2 Nitrogen adsorption-desorption isotherms and pore size distribution of the mesoporous silica support prepared in the embodiments of the present invention. Detailed Implementation
[0025] The technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.
[0026] Example 1
[0027] This embodiment provides a method for preparing PQQ and probiotic composite microcapsules, the specific steps of which are as follows: Preparation of S0 mesoporous silica support: 2.0 g of triblock copolymer P123 was weighed and added to 60 mL of 2.0 mol / L hydrochloric acid solution, and stirred at 40 °C until completely dissolved. 1.5 mL of 1,3,5-trimethylbenzene (TMB) was added as a pore-expanding agent, and stirring was continued for 2 hours. Subsequently, 4.2 g of tetraethyl orthosilicate (TEOS) was slowly added dropwise, and the reaction was carried out at 40 °C with constant stirring for 24 hours. The resulting suspension was transferred to a high-pressure reactor and hydrothermally aged at 130 °C for 48 hours. After the reaction, the suspension was filtered, washed, and dried at 80 °C. Finally, it was placed in a muffle furnace and heated to 650 °C at a rate of 2 °C / min, and calcined at this temperature for 6 hours to remove the surfactant. After natural cooling, the mesoporous silica support was obtained. Its microstructure is as follows: Figure 1 As shown. Carrier BET test results: as follows Figure 2 As shown in the corresponding test data, the mesoporous silica support prepared by this process has a specific surface area of 13.9263 m² / g, a total pore volume of 0.033898 cm³ / g, and an average pore size of 26.1010 nm. This large pore size characteristic is extremely beneficial for the deep confinement loading of PQQ molecules.
[0028] S1. Pore loading: Weigh 1 gram of the above mesoporous silica support and add it to 12.4 mL of PQQ solution with a concentration of 5 mg / mL. Stir at a constant temperature and in the dark for 24 hours. Centrifuge, wash, and vacuum dry.
[0029] S2. Adsorption of live bacteria: Disperse the loaded powder in a bacterial suspension containing 0.1 g (dry weight) of Lactobacillus acidophilus, and slowly stir at 4°C for 2 hours for adsorption.
[0030] S3. Crosslinking and coating: Add the precursor complex to an aqueous solution containing 2 grams of sodium alginate, mix well, and then dropwise into a 2% (w / w) curing and crosslinking solution (calcium chloride aqueous solution). After crosslinking and curing for 30 minutes, freeze dry.
[0031] Example 2
[0032] This embodiment provides a method for preparing PQQ and probiotic composite microcapsules, the specific steps of which are as follows: The preparation of the mesoporous silica support in step S0 is the same as in Example 1.
[0033] S1. Pore loading: Weigh 3 grams of the above mesoporous silica support and add it to 34.8 mL of PQQ solution with a concentration of 12.5 mg / mL. Stir at a constant temperature and in the dark for 24 hours. Centrifuge, wash, and vacuum dry.
[0034] S2. Adsorption of live bacteria: Disperse the loaded powder in a bacterial suspension containing 0.5 g (dry weight) of Lactobacillus acidophilus, and slowly stir at 15°C for 2 hours for adsorption.
[0035] S3. Crosslinking and coating: The precursor complex is added to an aqueous solution containing 6 grams of sodium alginate, mixed well, and then dripped into a 3.5% (w / w) curing and crosslinking solution (calcium chloride aqueous solution). After crosslinking and curing for 45 minutes, it is freeze-dried.
[0036] Example 3
[0037] This embodiment provides a method for preparing PQQ and probiotic composite microcapsules, the specific steps of which are as follows: The preparation of the mesoporous silica support in step S0 is the same as in Example 1.
[0038] S1. Pore loading: Weigh 5 g of the above mesoporous silica support and add it to 57 mL of PQQ solution with a concentration of 20 mg / mL. Stir at a constant temperature and in the dark for 24 hours. Centrifuge, wash, and vacuum dry.
[0039] S2. Adsorption of live bacteria: Disperse the loaded powder in a bacterial suspension containing 1.0 g (dry weight) of Lactobacillus acidophilus and slowly stir at 25°C for 2 hours for adsorption.
[0040] S3. Crosslinking and coating: Add the precursor complex to an aqueous solution containing 10 grams of sodium alginate, mix well, and then dropwise into a 5% (w / w) curing and crosslinking solution (calcium chloride aqueous solution). After crosslinking and curing for 60 minutes, freeze dry.
[0041] Example 4
[0042] This embodiment provides a method for preparing PQQ and probiotic composite microcapsules, the specific steps of which are as follows: The preparation of the mesoporous silica support in step S0 is the same as in Example 1.
[0043] S1. Pore loading: Weigh 3 grams of the above mesoporous silica support and add it to 34.8 mL of PQQ solution with a concentration of 12.5 mg / mL. Stir at a constant temperature and in the dark for 24 hours. Centrifuge, wash, and vacuum dry.
[0044] S2. Adsorption of live bacteria: The loaded powder is dispersed in a bacterial suspension containing 0.5 g (dry weight) of Bacillus subtilis, and slowly stirred at 15°C for 2 hours for adsorption.
[0045] S3. Crosslinking and coating: The precursor complex is added to an aqueous solution containing 6 grams of pectin, mixed well, and then dripped into a curing and crosslinking solution (zinc chloride aqueous solution) with a mass fraction of 3.5%. After crosslinking and curing for 45 minutes, it is freeze-dried.
[0046] Comparative Example 1: Pure Probiotics Take the Lactobacillus acidophilus suspension directly (1.0×10⁻⁶). 10 The probiotic powder was prepared by freeze-drying (CFU / mL) to obtain pure probiotic powder.
[0047] Comparative Example 2: PQQ-free empty microcapsules Weigh 3 grams of the mesoporous silica carrier prepared above and disperse it in a bacterial suspension containing 0.5 grams (dry weight) of Lactobacillus acidophilus. Adsorb at 15°C for 2 hours. Then add it to an aqueous solution containing 6 grams of sodium alginate. After mixing evenly, add it dropwise to a 3.5% curing and crosslinking solution (calcium chloride aqueous solution) for crosslinking and curing for 45 minutes, and freeze dry.
[0048] Comparative Example 3: Pure Bacillus subtilis powder
[0049] Pure bacterial powder was obtained by freeze-drying a suspension of Bacillus subtilis of equal concentration.
[0050] Comparative Example 4: PQQ-free empty Bacillus subtilis microcapsules
[0051] Using the same steps as in Comparative Example 4: PQQ-free empty Bacillus subtilis microcapsules, but omitting the PQQ loading step, empty microcapsules containing only Bacillus subtilis were prepared. Performance analysis test
[0052] (a) The composite microcapsules prepared in Examples 1-4 and the samples of Comparative Examples 1-4 were subjected to mesoporous parameters and morphology tests, gastric acid tolerance tests, and accelerated storage stability tests. The test methods are as follows: 1. PQQ loading rate (%) = (mass of loaded PQQ / mass of mesoporous silica carrier) × 100%.
[0053] 2. Mesoporous parameters and morphology testing: The morphology of the material was observed using a scanning electron microscope (SEM); the porosity was characterized using a fully automated surface area and pore size analyzer (BET).
[0054] 3. Gastric acid tolerance test: Prepare simulated gastric juice (containing pepsin, pH=1.5). Immerse the sample in the juice and treat at 37°C for 2 hours. After neutralization, spread the sample onto plates for viable bacterial count.
[0055] 4. Accelerated storage stability test: Each group of dry powder samples was sealed and placed in an environment of 37℃ and 75% relative humidity. The number of viable bacteria was measured on day 0, day 15 and day 30.
[0056] (ii) The above Example 1, Comparative Example 1, and Comparative Example 2 were tested for mesoporous parameters, gastric acid tolerance, and accelerated storage stability. The specific data are shown in Tables 1-3.
[0057] Table 1. Mesopore parameters and loading rate test in Example 1
[0058] Table 2 Data from the comparative test of gastric acid tolerance in Example 1
[0059] Table 3 Comparative test data of accelerated storage stability in Example 1
[0060] As shown in Table 1, compared to pure silica, the specific surface area and pore size of the core layer in Example 1 decreased significantly, indicating that even at the lower limit concentration (5 mg / mL), PQQ molecules successfully entered and occupied the inorganic mesoporous channels. Comparing the data in Tables 2 and 3, the survival rates of Comparative Examples 1 and 2 were extremely low or severely degraded, while the gastric acid survival rate of Example 1 reached 65.4%, decreasing by only 0.15 orders of magnitude after 30 days of storage. This fully demonstrates that the lower limit parameter conditions of the present invention can form a qualified physical and chemical dual barrier, and the small amount of PQQ released within the mesopores can still effectively eliminate oxidative stress, protecting probiotics at the cellular metabolic level.
[0061] The above-mentioned Example 2, Comparative Example 1, and Comparative Example 2 were subjected to tests on mesoporous parameters, gastric acid tolerance, and accelerated storage stability. The specific data are shown in Tables 4-6.
[0062] Table 4. Mesopore parameters and loading rate test in Example 2
[0063] Table 5. Comparative test data on gastric acid tolerance in Example 2
[0064] Table 6 Comparative test data of accelerated storage stability in Example 2
[0065] Analysis of the parameters in Table 4 shows that, under optimal conditions, the loading rate increased to 14.5%, indicating that PQQ filling within the pores reached an excellent state. Data in Tables 5 and 6 show that Example 2 exhibited the best protective performance among all groups, with a gastric acid survival rate as high as 78.6%, and almost no decrease in viable bacteria count after 30 days of accelerated aging (only a decrease of 0.06 orders of magnitude). The conclusion indicates that the (3:0.5:6) material ratio and the moderate cross-linking density of 3.5% used in Example 2 achieved the perfect balance. The coating layer possesses sufficient density to resist gastric acid erosion while simultaneously forming an optimal PQQ antioxidant microenvironment within, making it the optimal implementation scheme of this invention.
[0066] The mesoporous parameters, gastric acid tolerance, and accelerated storage stability of Example 3, Comparative Example 1, and Comparative Example 2 were tested, and the specific data are shown in Tables 7-9.
[0067] Table 7. Mesopore parameters and loading rate test in Example 3
[0068] Table 8. Comparative test data on gastric acid tolerance in Example 3.
[0069] Table 9 Comparative test data of accelerated storage stability in Example 3
[0070] As shown in Table 7, under the upper limit parameter conditions (20 mg / mL), the loading rate reached its highest level of 22.8%, while the specific surface area decreased to its lowest level, indicating that the carrier pores were close to saturated adsorption. Data from Tables 8 and 9 show that the gastric acid survival rate of Example 3 (71.2%) was slightly lower than that of Example 2, presumably because the higher cross-linking liquid concentration of 5% resulted in an overly dense coating layer, limiting the spatial activity of probiotics or the early release and diffusion of PQQ; however, it still exhibited a far superior protective effect compared to the comparative example. The conclusion demonstrates that even under the upper limit critical conditions of the scope of protection of this invention, the inorganic material-confined microscopic antioxidant factory mechanism can still operate efficiently, ensuring the vitality and functionality of the microecological preparation.
[0071] Comparing the data from Examples 1, 2, and 3, it was found that although Example 3 achieved the highest PQQ loading rate of 22.8%, its gastric acid survival rate and long-term storage stability were inferior to those of Example 2, which had a loading rate of 14.5%. This non-linear result confirms that a higher PQQ loading rate is not necessarily better; there is a highly correlated optimal range between the two.
[0072] When the loading rate is too high, the local concentration of PQQ released from the outer side of the encapsulation layer is too high, which can cause slight osmotic pressure stress on the probiotics on the surface. At the same time, in order to match the extremely high carrier dosage, the highest concentration (5%) of calcium chloride was used in Example 3 for high-density cross-linking, which resulted in an overly dense sodium alginate network, which to some extent limited the physical spatial activity of the probiotics. In contrast, Example 2, with its moderate PQQ concentration and suitable degree of cross-linking, achieved the most perfect balance between the "antioxidant microenvironment" and the "physical activity of the bacteria". The attainment of this optimal range is not obvious in the art.
[0073] The above Example 4, Comparative Example 3, and Comparative Example 4 were subjected to gastric acid tolerance and accelerated storage stability tests. The specific data are shown in Tables 10 and 11.
[0074] Table 10 Data from the comparative test of gastric acid tolerance in Example 4
[0075] Table 11 Comparative test data of accelerated storage stability in Example 4
[0076] As shown in Tables 10 and 11, the survival rate of unprotected pure Bacillus subtilis after gastric acid treatment is extremely low (<0.0001%), and the protective effect of conventional empty microcapsules remains limited. However, the composite microcapsules prepared in Example 4 of this invention successfully achieved a gastric acid survival rate of 76.5% for Bacillus subtilis, and the number of viable bacteria decreased by only 0.09 orders of magnitude after 30 days of accelerated storage. The protective mechanism of the composite microcapsules of this invention lies in the physical spatial confinement of micron-sized bacteria by the mesoporous material and the universal antioxidant microenvironment constructed by PQQ release. Since common probiotics such as Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, and Bacillus subtilis share homology in morphological size (micron-sized) and sensitivity mechanisms to gastric acid and oxygen free radicals, the data from Example 4 fully support and confirm that the molecular sieving and microenvironment protection mechanism of this invention has a highly universal protective effect on all types of common intestinal probiotics as defined in the claims. Example 4 uses pectin and zinc chloride to replace sodium alginate and calcium chloride. The gastric acid survival rate and storage stability showed a similar trend to Example 2, proving that the alternative solution of the present invention still has excellent protective effect.
[0077] The above description is merely a preferred embodiment of the present invention, but the scope of protection of the present invention is not limited thereto. Any equivalent substitutions or modifications made by those skilled in the art within the scope of the technology disclosed in the present invention, based on the technical solution and inventive concept of the present invention, should be covered within the scope of protection of the present invention.
Claims
1. A PQQ and probiotic composite microcapsule, characterized in that, It has a core-shell structure and consists of a core layer, a live bacteria layer, and a coating layer from the inside out. The core layer is a mesoporous silica carrier loaded with PQQ or its disodium salt. The live bacteria layer is a probiotic group physically adsorbed and fixed on the outer surface of the core layer. The coating layer is an enteric polymer cross-linked network layer wrapped around the outermost layer.
2. The PQQ and probiotic composite microcapsule according to claim 1, characterized in that, The mesoporous silica support has an average pore size of 10–40 nm and a specific surface area of 10–100 m² before loading. 2 / g.
3. The PQQ and probiotic composite microcapsule according to claim 1, characterized in that, The mass ratio of the core layer, the live bacteria layer and the coating layer is (1-5):(0.1-1):(2-10), wherein the live bacteria layer is based on dry weight.
4. The PQQ and probiotic composite microcapsule according to claim 1, characterized in that, The probiotics are selected from one or more of Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, or Bacillus subtilis.
5. The PQQ and probiotic composite microcapsule according to claim 1, characterized in that, The coating layer is made of sodium alginate or pectin, and is formed by cross-linking of divalent metal ions to form an enteric polymer cross-linked network layer.
6. A method for preparing a PQQ and probiotic composite microcapsule according to any one of claims 1 to 5, characterized in that, Includes the following steps: S0. Preparation of mesoporous silica support: Mesoporous silica support was prepared by a sol-gel combined with hydrothermal method with added pore-expanding agent; surfactant was weighed and dissolved in hydrochloric acid solution, pore-expanding agent was added and stirred homogeneously, and then tetraethyl orthosilicate was added dropwise to induce hydrolysis and polycondensation reaction; after the reaction was completed, it was transferred to a high-pressure reactor for high-temperature hydrothermal aging to expand the pores; after washing and drying, the product was placed in a muffle furnace for high-temperature calcination to remove the surfactant, and the mesoporous silica support was obtained. S1. Pore loading: Prepare an aqueous solution of PQQ or its disodium salt with a concentration of 5-20 mg / mL, and disperse the mesoporous silica support obtained in step S0 in the aqueous solution; stir under constant temperature and in the dark for 12-24 hours to allow PQQ molecules to fully enter and be physically adsorbed and fixed inside the mesoporous channels; then centrifuge and wash with deionized water to remove unadsorbed free PQQ on the surface, and finally dry in a vacuum drying oven to obtain the core layer powder loaded with PQQ. S2, Live Bacteria Adsorption: Collect freshly cultured or resuspended probiotic suspensions; add the core layer powder obtained in step S1 to the bacterial suspension, and gently stir and adsorb for 1 to 3 hours in an environment of 4℃~25℃; in this step, larger probiotics cannot enter the mesoporous channels, but are physically adsorbed and fixed on the outer surface of the mesoporous silica carrier, thereby obtaining the precursor complex. S3, Cross-linking coating: Dissolve the enteric polymer in deionized water to prepare an enteric polymer aqueous solution; add the above precursor complex directly to the enteric polymer aqueous solution and mix evenly to form a coating solution; Using a drop-addition device, the coating liquid is added drop by drop into a curing crosslinking liquid containing divalent metal cations with a mass fraction controlled at 2% to 5%; the droplets undergo ion exchange and crosslinking reactions upon contact with the curing crosslinking liquid, forming a dense microcapsule structure. After being cured in the curing crosslinking liquid for 30 to 60 minutes, it was filtered and collected, washed and freeze-dried to finally obtain composite microcapsules in dry powder form.
7. The method for preparing a PQQ and probiotic composite microcapsule according to claim 6, characterized in that, The surfactant in step S0 is triblock copolymer P123, and the pore-expanding agent is 1,3,5-trimethylbenzene.
8. The method for preparing a PQQ and probiotic composite microcapsule according to claim 6, characterized in that, The enteric polymer mentioned in step S3 is sodium alginate, and the divalent metal cation is calcium ion or zinc ion.
9. The application of a PQQ and probiotic composite microcapsule according to any one of claims 1 to 5, characterized in that, PQQ combined with probiotic microcapsules is used in the preparation of foods, health products, or drugs that improve gut microbiota, promote intestinal mucosal repair, or have anti-aging effects on mitochondria.
